Buyer Lise J
Known title: DirectorCIK: 0001295975
Associated companies
Transaction History
| TTD | ▲ Buy | Grant | 4,901 | $0 | 5/27/2025 | View on chart |
| TTD | ▲ Buy | Grant | 1,577 | $0 | 5/28/2024 | View on chart |
| TTD | ▼ Sell | Open Market | 4,000 | $304K | 6/13/2023 | View on chart |
| TTD | ▼ Sell | Open Market | 10,000 | $752K | 6/9/2023 | View on chart |
| TTD | ▼ Sell | Open Market | 10,000 | $751K | 6/8/2023 | View on chart |
| TTD | ▲ Buy | Grant | 2,119 | $0 | 5/25/2023 | View on chart |
| TTD | ▲ Buy | Grant | 4,178 | $0 | 5/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
TTD down 77% while market rises; healthcare integration news
The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.
TTD down 77% while market rises; healthcare integration news. The Trade Desk shares have fallen 77% while the broader market has risen, leading to comparisons with other ad-tech stocks like Alphabet and AppLovin. Recent news highlights a healthcare inventory integration with OptimizeRx, which may be relevant to its advertising capabilities. Despite the significant price drop, the stock trades at a trailing P/E of 13.8, well below its 52-week high of $56.39.